MFS
CPRX

Mirabella Financial Services’s Catalyst Pharmaceutical CPRX Stock Holding History

Mirabella Financial Services’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-15,597
Closed -$129K – 503
2022
Q1 		$129K Buy
+15,597
New +$110K 0.01% 424

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mirabella Financial Services's CPRX Position: Q2 2022 in Review

Mirabella Financial Services sold out of Catalyst Pharmaceutical (CPRX) in Q2 2022, closing a stake of 15,597 shares — an estimated $129K sold.

Mirabella Financial Services first reported a position in CPRX in Q1 2022 and held it in 1 quarter. The position peaked at $129K in Q1 2022. 189 funds tracked by Wall St. Rank hold CPRX as of Q2 2022.

  • Mirabella Financial Services reported no remaining Catalyst Pharmaceutical position as of Q2 2022 after selling out during the quarter.
  • Mirabella Financial Services sold 15,597 Catalyst Pharmaceutical shares in Q2 2022, an estimated $129K.
  • Mirabella Financial Services first reported a position in Catalyst Pharmaceutical in Q1 2022 and held it in 1 quarter.
  • Mirabella Financial Services's Catalyst Pharmaceutical position peaked at $129K in Q1 2022.
  • 189 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2022.

Based on Mirabella Financial Services's 13F filing for Q2 2022, filed 12 Aug 2022.